Biomedical Chromatography · 2003 · 24 citations · 4 references
PharmacyPharmaceuticsPharmacologyAnalytical ToxicologyMass Spectrometric AnalysisSteroid BiochemistryBioanalytical Method ValidationLiquid ChromatographyMass SpectrometryMetabolite ExtractionMetabolite IdentificationMetabolite QuantificationInternal Standard AnalysisLinear RangeLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisLiquid Chromatography-mass Spectrometry Method DevelopmentLower Limit Of QuantificationLower Limit Of QuantitationMetabolite Assay Development
A sensitive, rapid and selective liquid chromatography negative electrospray ionization tandem mass spectrometry [LC-(-)ESI-MS-MS] method has been developed and validated for the simultaneous quantification of budesonide (BUD) and its major metabolites, 6beta-hydroxybudesonide (OH-BUD) and 16alpha-hydroxyprednisolone (OH-PRED) in human plasma. The method was validated over a linear range from 0.1 to 10 ng/mL for all three analytes using a solid-phase extraction procedure with 9-fluoro-hydrocortisone as the internal standard. The between-day and within-day coefficients of variation for all compounds were < or =20% at the concentrations of lower limit of quantification and < or =15% at other quality control concentrations. The utility of this assay was demonstrated by monitoring BUD, OH-BUD and OH-PRED plasma concentrations in one healthy subject for 24 h following a 3 mg oral dose of budesonide, administered as a pH modified release capsule (Budenofalk) to healthy volunteers.
4
Karin Kronkvist, M. L. Gustavsson, Anna-Karin Wendel et al. · Journal of Chromatography A · 1998 · 33 citations
Yuan Nian Li, Bruce N. Tattam, Kenneth Brown et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1996 · 25 citations
Yuan N. Li, Bruce N. Tattam, Kenneth Brown et al. · Journal of Chromatography B Biomedical Sciences and Applications · 2001 · 19 citations